AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Teceris Injection

Prescription Icon
Prescription Required

Marketer

Mylan Pharmaceuticals Pvt Ltd - A Viatris Company

Salt Composition

Eribulin Mesylate (0.5mg/ml)

Overview Teceris Injection

Oncaspar injection is indicated for treating metastatic breast cancer in adults who have already undergone prior anticancer therapies. Administered intravenously under medical supervision, it may be used alone or in combination with other medications as part of a chemotherapy regimen. Dosage and frequency are determined individually by your physician and may vary over time; adhere strictly to prescribed instructions to minimize the risk of severe adverse effects. Therapeutic benefits may not be immediately apparent; discontinue use only as directed by your doctor. Common side effects include fatigue, alopecia, nausea, and bowel irregularities. This medication can suppress blood cell production, increasing infection risk; regular blood tests monitoring blood counts, cardiac function, liver health, uric acid, and electrolytes are essential. Peripheral neuropathy (numbness, tingling, or pins and needles in extremities) may occur; report persistent or bothersome symptoms promptly to your physician. Prior to initiating treatment, inform your physician about any pre-existing cardiac, hepatic, or renal conditions, or concurrent use of anti-infectives or other medications. Interaction with numerous other drugs is possible, so comprehensive medication disclosure is crucial. This medication is contraindicated in pregnancy and lactation; reliable contraception is imperative for both partners during treatment.

Uses of Teceris Injection

Breast cancer with distant spread

Major Benefits of Teceris Injection:

Administering this medication will be done by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Teceris Injection:

  • Anemia (low number of red blood cells)
  • Weakness
  • Hair loss
  • Nausea
  • Constipation
  • Decreased white blood cell count
  • Fatigue
  • Peripheral neuropathy (tingling and numbness of feet and hand)

How to use Teceris Injection:

This medication will be administered by your healthcare provider; self-medication is strictly prohibited.

How Teceris Injection works:

Teceris Injection is a cancer treatment that disrupts microtubule function, essential for cancer cell division and proliferation. This disruption halts the cancerous cell cycle, leading to cell death.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Teceris Injection presents an unknown safety profile. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Teceris Injection during pregnancy is contraindicated due to confirmed risks to the fetus. Nevertheless, in exceptional life-threatening circumstances, a physician might deem its use justifiable if the potential benefits outweigh the inherent hazards. Physician consultation is essential.

Breast feedingBreast feedingUNSAFE

Administration of Teceris Injection is contraindicated while breastfeeding due to potential infant toxicity.

DrivingDrivingUNSAFE

Administering Teceris Injection might reduce attentiveness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if such effects are experienced.

KidneyKidneyCAUTION

Careful administration of Teceris Injection is advised for individuals with impaired kidney function. Dosage modification of Teceris Injection might be necessary. Seek medical guidance.

LiverLiverCAUTION

Individuals with hepatic impairment should use Teceris Injection cautiously; dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Teceris Injection :

NA

Facts to Know About Teceris Injection

LabelValue
Chemical Type Halichondrin B analog
Developing Habits No.
Treatment Category Cancer Therapeutics
Action Class Microtubule-Targeting Agents (Non-Taxane)

FAQs on Teceris Injection

Teceris Injection may cause hair loss, a side effect that can range in severity and may be reversible. Discuss any hair loss concerns with your doctor.
Teceris Injection is typically administered on days 1 and 8 of each 21-day treatment cycle. Treatment length is individualized, with the number of cycles determined by your physician. Based on blood test results, your doctor may postpone administration or adjust the dosage.
A doctor or healthcare professional will administer Teceris Injection intravenously over 2 to 5 minutes. Dosage is determined by your body surface area (m²), calculated from your weight and height, and may be adjusted based on blood test results or other factors. Following Teceris Injection, a saline flush is recommended to ensure complete delivery.
Teceris Injection carries serious risks, including a dangerously low white blood cell count (neutropenia), potentially causing fatal infections. Numbness, tingling, or pain in the hands and feet (peripheral neuropathy) are also possible, sometimes severe and common with this injection. Use during pregnancy may harm the baby.
Women of childbearing age must use reliable contraception for three months following Teceris Injection treatment. This medication can cause severe birth defects and should not be used during pregnancy unless deemed absolutely essential after a thorough risk assessment for both mother and child.
Handle Teceris Injection with care, avoiding contact with skin, eyes, mouth, or nose. Wear gloves, goggles, and protective clothing. In case of skin contact, wash thoroughly with soap and water. If contact occurs with eyes, mouth, or nose, flush the area thoroughly with water. Pregnant personnel should not handle this medication.
Administer Teceris Injection only under the supervision of a physician experienced in cancer chemotherapy. It must be diluted in a maximum of 100 ml of 0.9% sodium chloride solution (9 mg/ml) – not 5% dextrose – and given by a healthcare professional.
Teceris Injection
26,167
MRP 31,879
17% off